Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections
Table 1
Baseline characteristics of the participants.
Characteristics
ITT group
PP group
Number
84
80
Mean age, years ± SD
57.37 ± 7.62
57.41 ± 7.73
Male, n (%)
34 (40.5)
32 (40.0)
Height, m ± SD
1.62 ± 0.08
1.61 ± 0.73
Weight, kg ± SD
63.6 ± 9.99
63.78 ± 10.18
BMI, kg/m2 ± SD
24.23 ± 2.81
24.27 ± 2.85
Alcohol, n (%)
18 (21.4)
18 (22.5)
Smoking, n (%)
11 (13.1)
11 (13.8)
DM, n (%)
8 (9.5)
8 (10.0)
HTN, n (%)
29 (34.5)
29 (36.3)
CVA, n (%)
3 (3.6)
3 (3.8)
Liver disease, n (%)
6 (7.1)
6 (7.5)
Others, n (%)
20 (23.8)
18 (22.5)
NSAIDS or antithrombotic agent, n (%)
9 (10.7)
9 (11.25)
With peptic ulcer, n (%)
21 (25.0)
20 (25.0)
ITT: intention-to-treat; PP: per protocol; SD: standard deviation; BMI: body mass index; DM: diabetes mellitus; HTN: hypertension; CVA: cerebrovascular accident; NSAIDs: nonsteroidal anti-inflammatory drugs.
